O54949 (NLK_MOUSE) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 112.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Serine/threonine-protein kinase NLK EC=2.7.11.24 Alternative name(s): Nemo-like kinase | ||
| Gene names |
| ||
| Organism | Mus musculus (Mouse) [Reference proteome] | ||
| Taxonomic identifier | 10090 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Mus › Mus![]() |
Protein attributes
| Sequence length | 527 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Serine/threonine-protein kinase that regulates a number of transcription factors with key roles in cell fate determination. Positive effector of the non-canonical Wnt signaling pathway, acting downstream of WNT5A, MAP3K7/TAK1 and HIPK2. Activation of this pathway causes binding to and phosphorylation of the histone methyltransferase SETDB1. The NLK-SETDB1 complex subsequently interacts with PPARG, leading to methylation of PPARG target promoters at histone H3K9 and transcriptional silencing. The resulting loss of PPARG target gene transcription inhibits adipogenesis and promotes osteoblastogenesis in mesenchymal stem cells (MSCs). Negative regulator of the canonical Wnt/beta-catenin signaling pathway. Binds to and phosphorylates TCF7L2/TCF4 and LEF1, promoting the dissociation of the TCF7L2/LEF1/beta-catenin complex from DNA, as well as the ubiquitination and subsequent proteolysis of LEF1. Together these effects inhibit the transcriptional activation of canonical Wnt/beta-catenin target genes. Negative regulator of the Notch signaling pathway. Binds to and phosphorylates NOTCH1, thereby preventing the formation of a transcriptionally active ternary complex of NOTCH1, RBPJ/RBPSUH and MAML1. Negative regulator of the MYB family of transcription factors. Phosphorylation of MYB leads to its subsequent proteolysis while phosphorylation of MYBL1 and MYBL2 inhibits their interaction with the coactivator CREBBP. Other transcription factors may also be inhibited by direct phosphorylation of CREBBP itself. Acts downstream of IL6 and MAP3K7/TAK1 to phosphorylate STAT3, which is in turn required for activation of NLK by MAP3K7/TAK1. Ref.1 Ref.4 Ref.5 Ref.6 Ref.7 Ref.8 Ref.9 Ref.10 Ref.11 Ref.12 Ref.13 Ref.15 Ref.16 Ref.17 Ref.18 Ref.19 |
| Catalytic activity | |
| Cofactor | |
| Enzyme regulation | Activated by the non-canonical Wnt signaling pathway, in which WNT5A leads to activation of MAP3K7/TAK1 and HIPK2, which subsequently phosphorylates and activates this protein. Activated by dimerization and subsequent intermolecular autophosphorylation on Thr-298. Other cytokines such as IL6 may also activate this regulatory circuit. Ref.1 Ref.4 Ref.6 Ref.12 Ref.19 |
| Subunit structure | Interacts with RNF138/NARF By similarity. Forms a complex with CHD7, PPARG and SETDB1 in response to WNT5A signaling By similarity. Interacts with DAPK3/ZIPK, and this interaction may disrupt interaction with transcription factors such as TCF7L2/TCF4 By similarity. Interacts with FOXO1 and FOXO3 By similarity. Homodimer. Homodimerization is required for intermolecular autophosphorylation, kinase activation and nuclear localization. Interacts with the upstream activating kinases HIPK2 and MAP3K7/TAK1. Interaction with MAP3K7/TAK1 seems to be indirect, and may be mediated by other proteins such as STAT3, TAB1 and TAB2. Interacts with and phosphorylates a number of transcription factors including FOXO4, LEF1, MYB, MYBL1, MYBL2, NOTCH1 and TCF7L2/TCF4. May interact with components of cullin-RING-based SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complexes. Interacts with MEF2A. Ref.7 Ref.9 Ref.10 Ref.11 Ref.12 Ref.13 Ref.15 Ref.16 Ref.17 Ref.18 Ref.19 |
| Subcellular location | Nucleus. Cytoplasm. Note: Predominantly nuclear. A smaller fraction is cytoplasmic. Ref.1 Ref.19 |
| Tissue specificity | Expressed at high levels in the brain, and at lower levels in heart, kidney, lung and liver. Ref.1 |
| Domain | Contains a TQE activation loop motif in which autophosphorylation of the threonine residue (Thr-298) is sufficient for kinase activation. This mode of activation contrasts with that of classical MAP kinases, which contain a TXY activation loop motif in which phosphorylation of both the threonine and tyrosine residues is required for kinase activation. |
| Post-translational modification | Phosphorylated on Thr-298. Intermolecular autophosphorylation on Thr-298 activates the enzyme. Ref.1 Ref.4 Ref.16 Ref.19 |
| Sequence similarities | Belongs to the protein kinase superfamily. CMGC Ser/Thr protein kinase family. MAP kinase subfamily. Contains 1 protein kinase domain. |
| Sequence caution | The sequence AAC24499.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally extended. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| Hipk2 | Q9QZR5 | 2 | EBI-366894,EBI-366905 |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 527 | 527 | Serine/threonine-protein kinase NLK | PRO_0000186337 | |||||
Regions | |||||||||
| Domain | 138 – 427 | 290 | Protein kinase | ||||||
| Nucleotide binding | 144 – 152 | 9 | ATP By similarity | ||||||
| Region | 1 – 304 | 304 | Required for interaction with TAB2 | ||||||
| Region | 1 – 125 | 125 | Sufficient for interaction with DAPK3 By similarity | ||||||
| Region | 124 – 416 | 293 | Sufficient for interaction with DAPK3 By similarity | ||||||
| Region | 428 – 527 | 100 | Required for homodimerization and kinase activation and localization to the nucleus | ||||||
| Region | 434 – 527 | 94 | Required for interaction with TAB2 | ||||||
| Motif | 298 – 300 | 3 | TQE | ||||||
| Compositional bias | 22 – 25 | 4 | Poly-Ala | ||||||
| Compositional bias | 27 – 34 | 8 | Poly-His | ||||||
| Compositional bias | 42 – 48 | 7 | Poly-His | ||||||
| Compositional bias | 71 – 83 | 13 | Poly-Ala | ||||||
| Compositional bias | 106 – 111 | 6 | Poly-Ala | ||||||
| Compositional bias | 115 – 119 | 5 | Poly-Ala | ||||||
Sites | |||||||||
| Active site | 264 | 1 | Proton acceptor By similarity | ||||||
| Binding site | 167 | 1 | ATP Probable | ||||||
Amino acid modifications | |||||||||
| Modified residue | 298 | 1 | Phosphothreonine; by autocatalysis Ref.14 Ref.19 | ||||||
| Modified residue | 522 | 1 | Phosphoserine By similarity | ||||||
Experimental info | |||||||||
| Mutagenesis | 167 | 1 | K → M: Abrogates kinase activity and autophosphorylation. Retains ability to homodimerize. Abrogates ability to induce ubiquitination and degradation of LEF1 and repress canonical Wnt/beta-catenin signaling. Abrogates ability to induce MYB degradation, and reduces ability to repress MYBL1 and MYBL2. Ref.1 Ref.4 Ref.7 Ref.10 Ref.12 Ref.16 Ref.17 Ref.19 | ||||||
| Mutagenesis | 298 | 1 | T → D or E: Abrogates autophosphorylation. Ref.1 Ref.10 Ref.19 | ||||||
| Mutagenesis | 298 | 1 | T → V: Abrogates autophosphorylation. Retains ability to homodimerize. Abrogates ability to induce MYB degradation. Ref.1 Ref.10 Ref.19 | ||||||
| Mutagenesis | 437 | 1 | C → S: Retains kinase activity. Ref.4 Ref.19 | ||||||
| Mutagenesis | 437 | 1 | C → Y: Abrogates homodimerization and intermolecular autophosphorylation, with consequent loss of kinase activity. Loss of nuclear localization. Ref.4 Ref.19 | ||||||
| Sequence conflict | 69 | 1 | S → P in AAC24499. Ref.1 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Nlk is a murine protein kinase related to Erk/MAP kinases and localized in the nucleus." Brott B.K., Pinsky B.A., Erikson R.L. Proc. Natl. Acad. Sci. U.S.A. 95:963-968(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, ENZYME REGULATION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AUTOPHOSPHORYLATION, MUTAGENESIS OF LYS-167 AND THR-298. Strain: BALB/c. Tissue: Brain. |
| [2] | "Lineage-specific biology revealed by a finished genome assembly of the mouse." Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S. Ponting C.P.PLoS Biol. 7:E1000112-E1000112(2009) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. Strain: C57BL/6J. |
| [3] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Strain: C57BL/6 and FVB/N. Tissue: Brain and Kidney. |
| [4] | "The TAK1-NLK-MAPK-related pathway antagonizes signalling between beta-catenin and transcription factor TCF." Ishitani T., Ninomiya-Tsuji J., Nagai S., Nishita M., Meneghini M., Barker N., Waterman M., Bowerman B., Clevers H., Shibuya H., Matsumoto K. Nature 399:798-802(1999) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, AUTOPHOSPHORYLATION, ENZYME REGULATION, MUTAGENESIS OF LYS-167 AND CYS-437. |
| [5] | "Abnormal bone marrow stroma in mice deficient for nemo-like kinase, Nlk." Kortenjann M., Nehls M., Smith A.J., Carsetti R., Schuler J., Kohler G., Boehm T. Eur. J. Immunol. 31:3580-3587(2001) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [6] | "The TAK1-NLK mitogen-activated protein kinase cascade functions in the Wnt-5a/Ca(2+) pathway to antagonize Wnt/beta-catenin signaling." Ishitani T., Kishida S., Hyodo-Miura J., Ueno N., Yasuda J., Waterman M., Shibuya H., Moon R.T., Ninomiya-Tsuji J., Matsumoto K. Mol. Cell. Biol. 23:131-139(2003) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, ENZYME REGULATION. |
| [7] | "Regulation of lymphoid enhancer factor 1/T-cell factor by mitogen-activated protein kinase-related Nemo-like kinase-dependent phosphorylation in Wnt/beta-catenin signaling." Ishitani T., Ninomiya-Tsuji J., Matsumoto K. Mol. Cell. Biol. 23:1379-1389(2003) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH LEF1 AND TCF7L2, MUTAGENESIS OF LYS-167. |
| [8] | "Nemo-like kinase suppresses a wide range of transcription factors, including nuclear factor-kappaB." Yasuda J., Yokoo H., Yamada T., Kitabayashi I., Sekiya T., Ichikawa H. Cancer Sci. 95:52-57(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [9] | "Role of the TAK1-NLK-STAT3 pathway in TGF-beta-mediated mesoderm induction." Ohkawara B., Shirakabe K., Hyodo-Miura J., Matsuo R., Ueno N., Matsumoto K., Shibuya H. Genes Dev. 18:381-386(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, CATALYTIC ACTIVITY, INTERACTION WITH STAT3. |
| [10] | "Wnt-1 signal induces phosphorylation and degradation of c-Myb protein via TAK1, HIPK2, and NLK." Kanei-Ishii C., Ninomiya-Tsuji J., Tanikawa J., Nomura T., Ishitani T., Kishida S., Kokura K., Kurahashi T., Ichikawa-Iwata E., Kim Y., Matsumoto K., Ishii S. Genes Dev. 18:816-829(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH MYB AND HIPK2, MUTAGENESIS OF LYS-167 AND THR-298. |
| [11] | "Differential sensitivity of v-Myb and c-Myb to Wnt-1-induced protein degradation." Kanei-Ishii C., Nomura T., Tanikawa J., Ichikawa-Iwata E., Ishii S. J. Biol. Chem. 279:44582-44589(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH MYB. |
| [12] | "The Wnt-NLK signaling pathway inhibits A-Myb activity by inhibiting the association with coactivator CBP and methylating histone H3." Kurahashi T., Nomura T., Kanei-Ishii C., Shinkai Y., Ishii S. Mol. Biol. Cell 16:4705-4713(2005) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, ENZYME REGULATION, INTERACTION WITH MYBL1 AND MYBL2, MUTAGENESIS OF LYS-167. |
| [13] | "Nemo-like kinase-myocyte enhancer factor 2A signaling regulates anterior formation in Xenopus development." Satoh K., Ohnishi J., Sato A., Takeyama M., Iemura S., Natsume T., Shibuya H. Mol. Cell. Biol. 27:7623-7630(2007) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, CATALYTIC ACTIVITY, INTERACTION WITH MEF2A. |
| [14] | "Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations." Munton R.P., Tweedie-Cullen R., Livingstone-Zatchej M., Weinandy F., Waidelich M., Longo D., Gehrig P., Potthast F., Rutishauser D., Gerrits B., Panse C., Schlapbach R., Mansuy I.M. Mol. Cell. Proteomics 6:283-293(2007) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-298, MASS SPECTROMETRY. Tissue: Brain cortex. |
| [15] | "Fbxw7 acts as an E3 ubiquitin ligase that targets c-Myb for nemo-like kinase (NLK)-induced degradation." Kanei-Ishii C., Nomura T., Takagi T., Watanabe N., Nakayama K.I., Ishii S. J. Biol. Chem. 283:30540-30548(2008) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH E3 UBIQUITIN-PROTEIN LIGASE COMPLEXES. |
| [16] | "TAB2 scaffolds TAK1 and NLK in repressing canonical Wnt signaling." Li M., Wang H., Huang T., Wang J., Ding Y., Li Z., Zhang J., Li L. J. Biol. Chem. 285:13397-13404(2010) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, AUTOPHOSPHORYLATION, INTERACTION WITH MAP3K7 AND TAB2, MUTAGENESIS OF LYS-167. |
| [17] | "Nemo-like kinase suppresses Notch signalling by interfering with formation of the Notch active transcriptional complex." Ishitani T., Hirao T., Suzuki M., Isoda M., Ishitani S., Harigaya K., Kitagawa M., Matsumoto K., Itoh M. Nat. Cell Biol. 12:278-285(2010) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH NOTCH1, MUTAGENESIS OF LYS-167. |
| [18] | "Oxidative stress-dependent regulation of Forkhead box O4 activity by nemo-like kinase." Szypowska A.A., de Ruiter H., Meijer L.A.T., Smits L.M.M., Burgering B.M.T. Antioxid. Redox Signal. 14:563-578(2011) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH FOXO4. |
| [19] | "Homodimerization of Nemo-like kinase is essential for activation and nuclear localization." Ishitani S., Inaba K., Matsumoto K., Ishitani T. Mol. Biol. Cell 22:266-277(2011) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, AUTOPHOSPHORYLATION, ENZYME REGULATION, HOMODIMERIZATION, SUBCELLULAR LOCATION, PHOSPHORYLATION AT THR-298, MUTAGENESIS OF LYS-167; THR-298 AND CYS-437. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AF036332 mRNA. Translation: AAC24499.1. Different initiation. AL591177, AL591376 Genomic DNA. Translation: CAI25549.2. AL591376, AL591177 Genomic DNA. Translation: CAI25603.2. BC057667 mRNA. Translation: AAH57667.2. BC058652 mRNA. Translation: AAH58652.2. |
| IPI | IPI00556914. |
| RefSeq | NP_032728.3. NM_008702.3. |
| UniGene | Mm.9001. |
3D structure databases | |
| ProteinModelPortal | O54949. |
| SMR | O54949. Positions 143-468. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | O54949. 2 interactions. |
PTM databases | |
| PhosphoSite | O54949. |
Proteomic databases | |
| PaxDb | O54949. |
| PRIDE | O54949. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENSMUST00000142739; ENSMUSP00000119345; ENSMUSG00000017376. |
| GeneID | 18099. |
| KEGG | mmu:18099. |
| UCSC | uc007kjw.1. mouse. |
Organism-specific databases | |
| CTD | 51701. |
| MGI | MGI:1201387. Nlk. |
Phylogenomic databases | |
| eggNOG | COG0515. |
| GeneTree | ENSGT00550000074298. |
| HOGENOM | HOG000233024. |
| HOVERGEN | HBG014652. |
| InParanoid | Q5SYE6. |
| KO | K04468. |
| OMA | CKCCYTT. |
Gene expression databases | |
| ArrayExpress | O54949. |
| Bgee | O54949. |
| CleanEx | MM_NLK. |
| Genevestigator | O54949. |
| GermOnline | ENSMUSG00000017376. Mus musculus. |
Family and domain databases | |
| InterPro | IPR011009. Kinase-like_dom. IPR003527. MAP_kinase_CS. IPR000719. Prot_kinase_cat_dom. IPR017441. Protein_kinase_ATP_BS. IPR002290. Ser/Thr_dual-sp_kinase_dom. IPR008271. Ser/Thr_kinase_AS. [Graphical view] |
| Pfam | PF00069. Pkinase. 1 hit. [Graphical view] |
| SMART | SM00220. S_TKc. 1 hit. [Graphical view] |
| SUPFAM | SSF56112. Kinase_like. 1 hit. |
| PROSITE | PS01351. MAPK. 1 hit. PS00107. PROTEIN_KINASE_ATP. 1 hit. PS50011. PROTEIN_KINASE_DOM. 1 hit. PS00108. PROTEIN_KINASE_ST. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| ChiTaRS | NLK. mouse. |
| NextBio | 293259. |
| SOURCE | Search... |
Entry information
| Entry name | NLK_MOUSE | ||||||||
| Accession | Primary (citable) accession number: O54949 Secondary accession number(s): Q5SYE6, Q6PF98 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
Relevant documents
| Human and mouse protein kinases Human and mouse protein kinases: classification and index |
| MGD cross-references Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
